Most likely, in the early stages of CKD, increased FGF-23 secretion allows normophosphatemia to be maintained, despite the increasing loss of renal excretory function and reduced expression of klotho protein in renal tubular cells. This evidence concerns the gene KL and chronic kidney disease.